PSI CRO

PSI CRO is a leading full-service global contract research organization that specializes in predictable patient enrollment and on-time project delivery across a broad therapeutic portfolio, including oncology, hematology, multiple sclerosis, infectious diseases, and radiopharmaceuticals. Leveraging rigorous feasibility assessments and a dedicated research team, PSI delivers accurate study timelines and high-quality data in more than 50 countries worldwide. The company’s no-nonsense, results-driven approach is reflected in its high client retention, referral rates, and low staff turnover. With a focus on Phase 2, Phase 3, and pivotal trials, PSI provides end-to-end clinical trial management, ensuring seamless execution from protocol design through regulatory submission.